Profile data is unavailable for this security.
About the company
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
- Revenue in USD (TTM)775.30k
- Net income in USD-35.32m
- Incorporated1998
- Employees110.00
- LocationVolitionRX Ltd1489 West Warm Springs Road, Suite 110HENDERSON 89014United StatesUSA
- Phone+1 (646) 650-1351
- Fax+65 6333-7235
- Websitehttps://volition.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Regencell Bioscience Holdings Ltd | 0.00 | -7.45m | 69.62m | 12.00 | -- | 4.08 | -- | -- | -0.5863 | -0.5863 | 0.00 | 1.31 | 0.00 | -- | -- | 0.00 | -82.73 | -- | -113.11 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 21.15 | -- | -- | -- |
| enVVeno Medical Corp | 0.00 | -23.52m | 69.65m | 31.00 | -- | 1.51 | -- | -- | -1.96 | -1.96 | 0.00 | 3.47 | 0.00 | -- | -- | 0.00 | -52.09 | -58.43 | -53.82 | -62.76 | -- | -- | -- | -260,799.30 | -- | -- | 0.00 | -- | -- | -- | 4.67 | -- | 21.58 | -- |
| Elutia Inc | 24.75m | -41.25m | 70.15m | 54.00 | -- | -- | -- | 2.83 | -2.20 | -2.08 | 1.35 | -1.66 | 0.4408 | 1.97 | 4.90 | 458,240.80 | -73.48 | -42.93 | -309.94 | -79.34 | 44.67 | 43.32 | -166.70 | -64.16 | 0.6367 | -3.54 | -- | -- | -49.69 | -8.71 | -25.39 | -- | 12.74 | -- |
| Landos Biopharma Inc | 0.00 | -21.94m | 70.15m | 19.00 | -- | 2.20 | -- | -- | -3.49 | -3.49 | 0.00 | 10.20 | 0.00 | -- | -- | 0.00 | -52.67 | -59.84 | -61.86 | -72.15 | -- | -- | -- | -795.80 | -- | -516.52 | 0.00 | -- | -- | -- | 44.15 | -- | -- | -- |
| Anebulo Pharmaceuticals Inc | 0.00 | -10.49m | 72.47m | 2.00 | -- | 11.17 | -- | -- | -0.4087 | -0.4087 | 0.00 | 0.2502 | 0.00 | -- | -- | 0.00 | -86.04 | -- | -95.37 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -71.89 | -- | -- | -- |
| Corvus Pharmaceuticals Inc | 0.00 | -27.03m | 72.58m | 28.00 | -- | 1.88 | -- | -- | -0.5642 | -0.5642 | 0.00 | 0.7889 | 0.00 | -- | -- | 0.00 | -47.51 | -38.31 | -56.21 | -43.34 | -- | -- | -- | -- | -- | -6.33 | 0.00 | -- | -- | -- | 34.57 | -- | -37.45 | -- |
| VolitionRX Ltd | 775.30k | -35.32m | 73.05m | 110.00 | -- | -- | -- | 94.23 | -0.504 | -0.504 | 0.0109 | -0.0953 | 0.0335 | -- | 4.92 | 7,048.18 | -154.29 | -111.92 | -- | -196.20 | -- | -- | -4,601.71 | -10,793.31 | -- | -280.52 | -- | -- | 153.04 | -- | -16.68 | -- | 29.13 | -- |
| Assembly Biosciences Inc | 7.16m | -61.23m | 73.25m | 65.00 | -- | 1.78 | -- | 10.23 | -14.02 | -14.02 | 1.63 | 7.50 | 0.06 | -- | 14.51 | 110,200.00 | -51.32 | -39.69 | -66.88 | -44.03 | -- | -- | -854.78 | -409.24 | -- | -- | 0.00 | -- | -- | -13.51 | 34.23 | -- | -5.59 | -- |
| Athira Pharma Inc | 0.00 | -117.67m | 73.59m | 65.00 | -- | 0.563 | -- | -- | -3.09 | -3.09 | 0.00 | 3.41 | 0.00 | -- | -- | 0.00 | -56.25 | -30.73 | -63.93 | -32.46 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -23.04 | -- | -- | -- |
| Assertio Holdings Inc | 152.07m | -331.94m | 74.58m | 53.00 | -- | 0.5386 | -- | 0.4904 | -3.97 | -3.97 | 2.04 | 1.46 | 0.4343 | 1.04 | 3.27 | 2,869,227.00 | -94.80 | -21.51 | -129.77 | -32.05 | 82.36 | 88.68 | -218.28 | -62.10 | 1.43 | -- | 0.2182 | -- | -2.67 | -13.38 | -402.80 | -- | -28.25 | -- |
| Connect Biopharma Holdings Ltd (ADR) | 0.00 | -59.50m | 74.94m | 81.00 | -- | 0.774 | -- | -- | -1.08 | -1.08 | 0.00 | 1.76 | -- | -- | -- | 0.00 | -- | -66.24 | -- | -71.36 | -- | -- | -- | -- | -- | -- | 0.0046 | -- | -- | -- | 49.61 | -- | 10.32 | -- |
| Passage Bio Inc | 0.00 | -102.06m | 75.17m | 58.00 | -- | 0.6024 | -- | -- | -1.87 | -1.87 | 0.00 | 2.03 | 0.00 | -- | -- | 0.00 | -51.80 | -48.56 | -56.80 | -52.09 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 25.02 | -- | -43.53 | -- |
| Cognition Therapeutics Inc | 0.00 | -25.79m | 75.27m | 25.00 | -- | 2.54 | -- | -- | -0.8564 | -0.8564 | 0.00 | 0.7609 | 0.00 | -- | -- | 0.00 | -60.26 | -- | -76.27 | -- | -- | -- | -- | -- | -- | -1,878.67 | 0.00 | -- | -- | -- | -20.52 | -- | -- | -- |
| Bakhu Holdings Corp | 0.00 | -1.92m | 75.33m | 2.00 | -- | -- | -- | -- | -0.0064 | -0.0064 | 0.00 | -0.0325 | 0.00 | -- | -- | 0.00 | -281.75 | -4,391.82 | -- | -- | -- | -- | -- | -- | -- | -8.39 | -- | -- | -- | -- | 33.37 | -- | -- | -- |
Data as of Apr 27 2024. Currency figures normalised to VolitionRX Ltd's reporting currency: US Dollar USD
7.55%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lagoda Investment Management LPas of 31 Dec 2023 | 3.73m | 4.54% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 615.92k | 0.75% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 568.57k | 0.69% |
| Geode Capital Management LLCas of 31 Dec 2023 | 557.41k | 0.68% |
| Bridgeway Capital Management LLCas of 31 Dec 2023 | 176.10k | 0.22% |
| Silverberg Bernstein Capital Management LLCas of 31 Mar 2024 | 144.62k | 0.18% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 135.67k | 0.17% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 123.92k | 0.15% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 89.55k | 0.11% |
| Spectrum Asset Management, Inc. (California)as of 31 Dec 2023 | 55.60k | 0.07% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
